Acute blindness during treatment of recurrent or metastatic nasopharyngeal carcinoma with doxorubicin and CCNU

Eur J Cancer. 1990;26(7):857. doi: 10.1016/0277-5379(90)90179-w.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Aged
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects*
  • Blindness / chemically induced*
  • Doxorubicin / adverse effects
  • Drug Evaluation
  • Female
  • Humans
  • Lomustine / adverse effects
  • Male
  • Middle Aged
  • Nasopharyngeal Neoplasms / drug therapy*

Substances

  • Lomustine
  • Doxorubicin